Nilotinib cause moyamoya disease in the treatment of chronic myelogenous leukemia during chronic phase: A case report

• Jin-ping Liang,
• Rui-hua Mi,
• Lin Chen,
• Xu-dong Wei

Affiliations

Jin-ping Liang

Department of Hematology, The Affiliated Tumor Hospital of Zhengzhou University, Henan Provincial Cancer Hospital, Zhengzhou, China

Rui-hua Mi

Department of Hematology, The Affiliated Tumor Hospital of Zhengzhou University, Henan Provincial Cancer Hospital, Zhengzhou, China

Lin Chen

Department of Hematology, The Affiliated Tumor Hospital of Zhengzhou University, Henan Provincial Cancer Hospital, Zhengzhou, China

Xu-dong Wei

Corresponding author. Department of Hematology, the Affiliated Tumor Hospital of Zhengzhou University, Henan Provincial Cancer Hospital, No. 127 Dongming Rd, Zhengzhou, 450008, Henan, China.; Department of Hematology, The Affiliated Tumor Hospital of Zhengzhou University, Henan Provincial Cancer Hospital, Zhengzhou, China